Cargando…

Drug safety of rosiglitazone and pioglitazone in France: a study using the French PharmacoVigilance database

BACKGROUND: Thiazolidinediones (TZDs), rosiglitazone (RGZ) and pioglitazone (PGZ) are widely used as hypoglycemic drugs in patients with type 2 diabetes mellitus. The aim of our study was to investigate the profile of adverse drug reactions (ADRs) related to TZDs and to investigate potential risk fa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Berthet, Stephanie, Olivier, Pascale, Montastruc, Jean-Louis, Lapeyre-Mestre, Maryse
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3119167/ https://www.ncbi.nlm.nih.gov/pubmed/21609444 http://dx.doi.org/10.1186/1472-6904-11-5

Ejemplares similares

Antidepressants and movement disorders: a postmarketing study in the world pharmacovigilance database
por: Revet, Alexis, et al.
Publicado: (2020)

Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance
por: Tambon, Marine, et al.
Publicado: (2021)

Considering sex-specific adverse drug reactions should be a priority in pharmacovigilance and pharmacoepidemiological studies
por: Lapeyre-Mestre, Maryse
Publicado: (2019)

Association between NMDAR antagonists, drug abuse and dependence: A disproportionality analysis from the WHO pharmacovigilance database
por: Revol, Bruno, et al.
Publicado: (2022)

Novel forms of injectable buprenorphine and French model of opioid use disorder treatment
por: Lapeyre-Mestre, Maryse
Publicado: (2020)

Identifying multiple myeloma patients using data from the French health insurance databases: Validation using a cancer registry
por: Palmaro, Aurore, et al.
Publicado: (2017)

French Pharmacovigilance Public System and COVID-19 Pandemic
por: Grandvuillemin, Aurélie, et al.
Publicado: (2020)

Cancer Risk of Anti-TNF-α at Recommended Doses in Adult Rheumatoid Arthritis: A Meta-Analysis with Intention to Treat and per Protocol Analyses
por: Moulis, Guillaume, et al.
Publicado: (2012)

Early Detection of Prescription Drug Abuse Using Doctor Shopping Monitoring From Claims Databases: Illustration From the Experience of the French Addictovigilance Network
por: Soeiro, Thomas, et al.
Publicado: (2021)

Analysis of heat stroke and heat exhaustion cases in EudraVigilance pharmacovigilance database
por: Gamboa, Lorea, et al.
Publicado: (2023)

Combatting the misuse of benzodiazepines and related Z drugs in French general practice: a clinical review
por: Gentile, Gaetan, et al.
Publicado: (2020)

Laboratory Monitoring of Patients Treated with Antihypertensive Drugs and Newly Exposed to Non Steroidal Anti-Inflammatory Drugs: A Cohort Study
por: Fournier, Jean-Pascal, et al.
Publicado: (2012)

French pharmacovigilance survey of casirivimab - imdevimab monoclonal antibodies in coronavirus disease (COVID-19)
por: de Canecaude, Claire, et al.
Publicado: (2023)

Rosiglitazone and Pioglitazone Alter Aromatase Kinetic Properties in Human Granulosa Cells
por: Araki, Takako, et al.
Publicado: (2011)

Utilisation trends of rosiglitazone and pioglitazone in Australia before and after safety warnings
por: Niyomnaitham, Suvimol, et al.
Publicado: (2014)

A Pharmacovigilance Study on the Safety of Axicabtagene Ciloleucel Based on Spontaneous Reports from the EudraVigilance Database
por: Rafaniello, Concetta, et al.
Publicado: (2023)

Pharmacovigilance of Risankizumab in the Treatment of Psoriasis and Arthritic Psoriasis: Real-World Data from EudraVigilance Database
por: Calapai, Fabrizio, et al.
Publicado: (2023)

Cross-national health care database utilization between Spain and France: results from the EPICHRONIC study assessing the prevalence of type 2 diabetes mellitus
por: Moulis, Guillaume, et al.
Publicado: (2018)

Drug–drug interactions with imatinib: An observational study
por: Récoché, Isabelle, et al.
Publicado: (2016)

Misuse and Dependence on Non-Prescription Codeine Analgesics or Sedative H1 Antihistamines by Adults: A Cross-Sectional Investigation in France
por: Roussin, Anne, et al.
Publicado: (2013)

Comment on: An Insight Into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions
por: Jouanjus, Emilie, et al.
Publicado: (2019)

Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study
por: Juurlink, David N, et al.
Publicado: (2009)

Local anesthetics systemic toxicity in children: analysis of the French pharmacovigilance database
por: Schweitzer-Chaput, Arnaud, et al.
Publicado: (2023)

Vaccination during the First Diagnosis of Multiple Myeloma: A Cohort Study of the French National Health Insurance Database
por: Tournaire, Guilhem, et al.
Publicado: (2020)

Addictovigilance contribution during COVID-19 epidemic and lockdown in France
por: Lapeyre-Mestre, Maryse, et al.
Publicado: (2020)

Immune Checkpoint Inhibitor-Related Cytopenias: About 68 Cases from the French Pharmacovigilance Database
por: Martin, Mickaël, et al.
Publicado: (2022)

Patterns of Tyrosine Kinase Inhibitor Utilization in Newly Treated Patients With Chronic Myeloid Leukemia: An Exhaustive Population-Based Study in France
por: Pajiep, Marie, et al.
Publicado: (2021)

Pharmaco-economic impact of demographic change on pharmaceutical expenses in Germany and France
por: Boecking, Wolfgang, et al.
Publicado: (2012)

Serious adverse drug reactions with hydroxychloroquine: a pharmacovigilance study in Vigibase®
por: Montastruc, Jean-Louis, et al.
Publicado: (2020)

Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head-to-Head Randomized Clinical Studies
por: Deeg, Mark A., et al.
Publicado: (2008)

Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs
por: Colhoun, H. M., et al.
Publicado: (2012)

Influence of health warnings on the use of rosiglitazone and pioglitazone in an area of Spain: A time-series study
por: Carracedo-Martínez, Eduardo, et al.
Publicado: (2016)

Development of Heart Failure in Medicaid Patients with Type 2 Diabetes Treated with Pioglitazone, Rosiglitazone, or Metformin
por: Breunig, Ian M., et al.
Publicado: (2014)

Propensity Score-Based Approaches in High Dimension for Pharmacovigilance Signal Detection: an Empirical Comparison on the French Spontaneous Reporting Database
por: Courtois, Émeline, et al.
Publicado: (2018)

Dual therapy of rosiglitazone/pioglitazone with glimepiride on diabetic nephropathy in experimentally induced type 2 diabetes rats
por: Rao, Ravi Prakash, et al.
Publicado: (2011)

Potentially Inappropriate Drug Prescribing in French Nursing Home Residents: An Observational Study
por: Qassemi, Soraya, et al.
Publicado: (2020)

The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety
por: Leonard, Charles E., et al.
Publicado: (2020)

Rosiglitazone and Pioglitazone Utilization from January 2007 Through May 2008 Associated With Five Risk-Warning Events
por: Starner, Catherine I., et al.
Publicado: (2008)

Immune check point inhibitors-induced hypophysitis: a retrospective analysis of the French Pharmacovigilance database
por: Garon-Czmil, Julie, et al.
Publicado: (2019)

Increase of high‐risk tramadol use and harmful consequences in France from 2013 to 2018: Evidence from the triangulation of addictovigilance data
por: Roussin, Anne, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_acutuaf6b3u4rms0t7cprl2000